HMB
Best-in-class: HMB
A leucine metabolite that reduces muscle-protein breakdown — most useful for preserving muscle during dieting, injury, aging or hard training.
HMB quick facts
| Suggested dose | 3 g daily (split). |
| How often | Daily |
| Who it's for | Muscle preservation while dieting, injured, aging, or over-reaching. |
The evidence pattern is clear and worth stating plainly. HMB works in catabolic states — bed rest, illness, aggressive dieting, untrained people starting out — and largely fails in well-fed resistance-trained lifters, who are not losing much protein to prevent. It is oversold to exactly the group it helps least. The free-acid form absorbs faster than the calcium salt, though whether that changes outcomes is unsettled.
How HMB actually works
Beta-hydroxy beta-methylbutyrate is a metabolite of leucine — roughly 5% of leucine is converted to it. Where leucine's main action is triggering protein synthesis via mTOR, HMB's appears to be primarily on the other side of the ledger: reducing proteolysis by downregulating the ubiquitin-proteasome pathway. That is a genuinely different lever on net protein balance.
Where to get HMB
Find HMB on iHerb →The evidence for HMB
Graded by what exists behind each claim.
✅ Clinically validated
- RCTs support reduced muscle damage and preserved lean mass in catabolic states (dieting, detraining, older adults).
- Anti-catabolic (muscle-sparing) more than muscle-building in well-fed lifters.
📊 Correlative data
- Muscle loss accelerates with age, illness and aggressive dieting — where HMB helps most.
🧪 Theoretical / extrapolated benefits
- Benefits in already-strong, well-fed athletes are smaller than in catabolic scenarios.
How to read these tiers: they say how much human evidence exists, not how well something works — and ✗ flags harm, never a disappointing trial. How the evidence tiers work →
What HMB actually does
HMB is not a supplement that happens to resemble a metabolite. It is the metabolite, and the enzyme that makes it has been named. Leucine is transaminated to alpha-ketoisocaproate, and a small fraction of that KIC is handled not by the mitochondrial branched-chain ketoacid dehydrogenase complex but by a cytosolic enzyme, KIC dioxygenase, which produces beta-hydroxy-beta-methylbutyrate. The step is not incidental: when protein synthesis was stimulated in rat myotubes, the effect required conversion of leucine to HMB by that dioxygenase rather than leucine itself Girón 2016. That is an unusually strong claim for a supplement to be able to make — the active molecule downstream of leucine was identified by removing the enzyme.
The pathway was then traced with a labeled tracer in a whole animal. A radiolabeled leucine absorption, distribution, metabolism and excretion study in the rat identified HMB as a metabolite of dietary leucine Lee 2015. So the supplement is a compound the body already makes from a food amino acid, which is a different starting position from most things on this shelf and is the honest basis for its safety record.
The arithmetic of that conversion is the reason the supplement exists at all. Only a few percent of leucine flux ends up as HMB. The position stands put the leucine equivalent of a standard 3 g daily HMB dose in the region of 60 g of leucine Wilson 2013 Rathmacher 2025 — an intake nobody reaches from food or from a protein shake. That gap, not a novel mechanism, is what a capsule is buying.
What HMB then does splits into two directions, and the anti-catabolic one is better supported. On the synthesis side it signals through mTORC1, the same node leucine acts on. On the breakdown side it attenuates ubiquitin-proteasome and autophagic proteolysis, which is why the effect sizes are largest where proteolysis is elevated — bed rest, illness, aggressive energy restriction, age — and smallest in a well-fed trained lifter whose breakdown rate is already low.
A third proposed route runs through cholesterol synthesis and is the least discussed. HMB is a precursor of beta-hydroxy-beta-methylglutaryl-CoA, and the membrane-repair hypothesis holds that damaged sarcolemma needs local cholesterol synthesis to reseal. It predicts an effect on damage markers rather than on hypertrophy, which is testable and is the shape most of the positive data takes.
Cell, rodent, human — and where it stops
Cell to rodent to human is unusually complete here, and the place it breaks is the population rather than the species.
In the dish. L6 rat myotubes, with the conversion enzyme manipulated, established that HMB and not leucine was the molecule driving the protein-synthesis response Girón 2016.
In the rat. A carbon-14 leucine ADME study followed the label through absorption, distribution, metabolism and excretion and found HMB among the metabolites Lee 2015. This is the step most supplements skip entirely.
In people, repeatedly, and now pooled twice. A position stand summarized the trial literature in 2013 Wilson 2013 and a new one was issued in 2025 Rathmacher 2025. An umbrella review of meta-analyses reported ergogenic benefits on body composition and muscle strength Bideshki 2025. An umbrella review is a review of reviews, which means it inherits every heterogeneity beneath it — and for HMB the heterogeneity has a name.
The obstacle is that the effect size depends on who is taking it, and the trials are not one population. HMB is anti-catabolic. In older adults, in bed rest, in energy restriction and in clinical catabolism there is something to prevent, and the trials in those groups are where the signal is. In trained, well-fed young lifters eating adequate protein, the proteolysis HMB attenuates is not elevated, and pooling those trials with the first group produces an average that describes nobody.
The second obstacle is that the trials do not all use the same chemical. Which is the form section, and it is not a technicality.
HMB — which form, and does it matter
Two forms are sold, the newer one is marketed as superior, and the head-to-head went the other way. HMB is sold as the calcium salt, calcium beta-hydroxy-beta-methylbutyrate monohydrate, and as the free acid in a gel capsule. The free acid was introduced on the argument that it reaches a higher peak concentration faster because it does not have to dissociate. A direct comparison found superior bioavailability for the calcium salt form rather than the free acid Ribeiro 2024. That is the opposite of the claim the premium is charged for.
The mass arithmetic is checkable and is worth doing before comparing labels. The HMB anion has a molecular weight of about 117 daltons. Calcium HMB monohydrate is that anion twice over, plus calcium and a water of hydration, for a formula weight near 292. So HMB is roughly 80% of calcium HMB by mass, and a 3 g scoop of the calcium salt delivers about 2.4 g of HMB. A free-acid product declaring 3 g delivers 3 g. Comparing the two by the number on the front of the tub compares different quantities of the same molecule.
Which makes the bioavailability result more interesting, not less. The calcium salt is at a mass disadvantage per gram of product and still came out ahead on exposure Ribeiro 2024. Anybody selling the free acid on kinetics now owes the reader an answer to that paper.
The trials that built the evidence base used the calcium salt. The bulk of the literature summarized by the position stands is calcium HMB Wilson 2013 Rathmacher 2025, so the cheaper form is also the studied form. This is the reverse of the usual situation on this shelf and it deserves saying plainly.
Timing claims follow from the form and are mostly overstated. The free acid's case rests on a faster peak, which would matter if HMB worked acutely around a session. The mechanism is chronic attenuation of proteolysis, and the position stands describe loading over weeks rather than dosing around a workout Rathmacher 2025. A faster peak of a compound whose effect is cumulative is a solution to a problem the molecule does not have.
What would have to be true, and how you would know it was not
1. Predict creatine kinase falls and total testosterone does not. The membrane-repair and anti-proteolytic mechanisms both predict reduced muscle damage. Baseline creatine kinase after a standardized session, repeat after four weeks of 3 g daily. Prediction: a lower post-exercise CK rise, with no change in testosterone, IGF-1 or cortisol, because none of those is in the pathway.
2. Predict the lean-mass effect is visible in a catabolic context and absent in a fed one. The umbrella review pools body composition and strength outcomes Bideshki 2025. The falsifiable version: in somebody in a deliberate energy deficit, DEXA-measured lean mass declines less over eight to twelve weeks than it would otherwise; in somebody eating at maintenance with adequate protein, it does nothing measurable. This prediction cuts against the product for most of the people buying it.
3. Predict no change in kidney or liver panels. The compound is an endogenous leucine metabolite Lee 2015, and the position stands report no consistent safety signal Rathmacher 2025. Baseline and twelve-week creatinine, eGFR, ALT and AST should be flat. A change means something else is happening.
4. Predict grip strength before one-rep maximum. Where HMB helps older adults, the mechanism is preservation rather than adaptation, so the sensitive measure is a simple functional one — grip strength, sit-to-stand time — on a twelve-week window, not a training-max test.
5. The prediction that would settle the form argument. Give matched HMB doses — not matched product masses — as calcium salt and as free acid, and measure plasma HMB over six hours. Prediction: the calcium salt holds its advantage Ribeiro 2024. If the free acid wins at matched HMB, the form section here is wrong and should be rewritten.
What nobody has tested yet
Nobody knows how much HMB a person makes on their own. The conversion is a small percentage of leucine flux and it has been traced in the rat Lee 2015. There is no published measurement of endogenous HMB production rate in a human across a range of protein intakes, which means the supplement's premise — that the endogenous route saturates well below a useful dose — is an inference rather than a measurement.
Nobody has tested the KIC dioxygenase step in people. The enzyme was manipulated in rat myotubes to show the conversion is required Girón 2016. Whether human variation in that enzyme's activity explains why some people respond and others do not is unstudied, and it is the obvious explanation for a heterogeneous literature.
Nobody has run the form comparison at a clinical endpoint. The salt versus free acid question has been answered on bioavailability Ribeiro 2024 and not on lean mass, strength or damage markers. A trial powered on an outcome rather than on a plasma curve has not been published.
And nobody has resolved the trained-lifter question with a single adequately powered trial. The umbrella review inherits the disagreement rather than settling it Bideshki 2025. One large, well-controlled trial in resistance-trained adults with verified protein intake would do more than another meta-analysis of the studies that already disagree.
HMB — its own safety story, not its category's
The safety story here is genuinely quiet, and the reason is structural rather than lucky. HMB is a metabolite the body already produces from leucine Lee 2015, so the exposure a supplement creates is a larger amount of something already present rather than a new molecule. The position stands report no consistent adverse effect pattern at the doses studied Wilson 2013 Rathmacher 2025. That is a claim about the trials, not a guarantee.
The calcium in the calcium salt is not nothing, and nobody counts it. Calcium HMB is roughly 14% calcium by mass, so a 3 g daily dose contributes several hundred milligrams of elemental calcium before any calcium supplement or fortified food is added. For most people that is irrelevant. For somebody already taking a calcium supplement, or with a history of calcium-containing kidney stones, it belongs in the running total.
There is no established drug interaction, and that is a statement about the absence of studies as much as about the molecule. No cytochrome pathway has been implicated, and HMB is not protein-bound in a way that would displace anything. What has not been done is a systematic interaction study, so the honest position is that none is known rather than that none exists.
The real risk with this product is opportunity cost, and it is worth naming. The effect is largest where catabolism is elevated Bideshki 2025. In a young, well-fed, resistance-trained person eating enough protein, 3 g of HMB is a purchase with a small expected effect, and the money and attention would do more elsewhere. That is not a safety finding; it is the honest limit, and it is the thing a supplement page is least likely to say.
Populations without data. Pregnancy, lactation and children are outside the trial base, and the position stands do not extend to them Rathmacher 2025. Chronic kidney disease is the other gap: an amino-acid metabolite given at gram doses in somebody with impaired clearance has not been studied, and inference from a healthy population does not cover it.
Sources read for this page
- Rathmacher JA. International society of sports nutrition position stand: beta-hydroxy-beta-methylbutyrate (HMB). J Int Soc Sports Nutr 2025 · PMID 39699070
- Ribeiro HR. Superior bioavailability of the calcium salt form of beta-hydroxy-beta-methylbutyrate compared with the free acid form. Amino Acids 2024 · PMID 38564019
- Girón MD. Conversion of leucine to beta-hydroxy-beta-methylbutyrate by alpha-keto isocaproate dioxygenase is required for a potent stimulation of protein synthesis in L6 rat myotubes. J Cachexia Sarcopenia Muscle 2016 · PMID 27065075
- Lee AJ. A (14)C-leucine absorption, distribution, metabolism and excretion (ADME) study in adult Sprague-Dawley rat reveals beta-hydroxy-beta-methylbutyrate as a metabolite. Amino Acids 2015 · PMID 25618754
- Wilson JM. International Society of Sports Nutrition Position Stand: beta-hydroxy-beta-methylbutyrate (HMB). J Int Soc Sports Nutr 2013 · PMID 23374455
- Bideshki MV. Ergogenic Benefits of beta-Hydroxy-beta-Methyl Butyrate (HMB) Supplementation on Body Composition and Muscle Strength: An Umbrella Review of Meta-Analyses. J Cachexia Sarcopenia Muscle 2025 · PMID 39797501
How you would know if it worked
There is no blood test for this one. That is not a criticism — it is a fact about the effect, and it changes how you should judge it.
- What to watch: Whether you keep what you already have — which means it can only be scored in a situation where you were otherwise going to lose it: a real caloric deficit, a limb in a cast, a layoff, a deliberately over-reaching block. Track body weight and one strength number through that period. In a well-fed lifter training normally there is nothing for it to prevent and no honest read-out exists.
- How long before it means anything: The length of the catabolic period itself — through the diet, through the layoff, through the block, with eight weeks a sensible minimum. The comparison that means something is against your own previous diet or layoff, not against a phase in which you were growing anyway.
- What will fool you: Expecting it to build rather than to protect. Its evidence is anti-catabolic and the two get conflated constantly, so a lifter who adds it during a surplus will credit it with normal progress. If you are dieting, weight falls in week one for water and glycogen reasons whatever you take — strength holding steady through the deficit is the real signal, and it is quiet enough that you need the numbers written down to see it at all.
Run it one variable at a time. Starting three things in one week means a result you cannot attribute, which is the same as no result.
HMB — safety & side effects
- Very well tolerated; no consistent side effects in the trials.
- No established drug interactions.
- The benefit case is strongest in older adults and during catabolic states, and weakest in trained young athletes — which is the honest limit rather than a safety one.
Not medical advice. If you take prescription medication or have a diagnosed condition, check this against it with a pharmacist or doctor — pharmacists are underused and free.
- When to take it, and what to take it with
- Which form actually absorbs
- Who it's worth it for
- Best-in-class brand pick
- Coach Cam's stacks and notes
- Fasted or with food, and when in the day
- Morning or night, and why that window
- Around training, or deliberately away from it
- What it must not share a window with
Everything above is free and stays free. Skool is where it becomes a plan — HMB in an order, with the rest of what you're running.
Unlock in Skool — $10/mo →Bloodwork to run alongside HMB
Baseline first, then again at 8–12 weeks.
| Marker | What it’s watching for |
|---|---|
| Complete Blood Count (CBC) with Differential | Hemoglobin sets your ceiling for endurance work |
| Ferritin | Low iron limits performance long before anemia shows |
| Total Testosterone | Drops under genuine overreaching |
| Comprehensive Metabolic Panel (CMP) | Kidney and electrolytes under heavy training load |
The Athletic Performance & Recovery panel covers these in one order — 12 markers, $207.90 with the discount applied.
Check results you already have → · All 103 markers A–Z
HMB — frequently asked questions
What is HMB?
A leucine metabolite that reduces muscle-protein breakdown — most useful for preserving muscle during dieting, injury, aging or hard training.
What is the suggested dose of HMB?
3 g daily (split). This is a general reference for education only — statements have not been evaluated by the FDA and this is not medical advice.
Where can I find HMB dosing and the full breakdown?
The suggested dose and the full evidence — clinical, correlative and theoretical — are on this page. What's inside Skool is when to take it, which form actually absorbs, the brand worth buying and Coach Cam's stacks.
Where can I buy HMB?
Coach Cam sources HMB from vetted, top-rated brands on iHerb — use the buy link on this page.
HMB inside a finished plan
One arm of 1 Protocol Blueprint, free to read in full.
What HMB is used for
HMB appears under 2 goals in the goal router.
Related Performance supplements
Where this goes next
HMB is the substrate arm of this plan. The page above is the free breakdown of one compound; the plan it belongs to — the dosing, the order to correct things in, the week-by-week schedule and what to retest — is a lesson inside Skool.